Biopharmaceutical Companies Acknowledge genOway as Their Preferred Provider for Genetically Modified Rodents

LYON, France--(BUSINESS WIRE)--genOway (Paris:ALGEN), the biotechnology company dedicated to the development of genetically modified rodent models, reports recent 2008 business achievements demonstrating that the company is viewed as the preferred provider by leading biopharmaceutical companies.